Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6421
    -0.0004 (-0.07%)
     
  • OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD

    2,406.70
    +8.70 (+0.36%)
     
  • Bitcoin AUD

    100,138.42
    +3,297.36 (+3.40%)
     
  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     
  • AUD/EUR

    0.6023
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0893
    +0.0018 (+0.17%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,037.65
    -356.67 (-2.05%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,986.40
    +211.02 (+0.56%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Top Ranked Momentum Stocks to Buy for April 25th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 25th:

Forty Seven, Inc. (FTSV): This clinical-stage immuno-oncology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.

Forty Seven, Inc. Price and Consensus

Forty Seven, Inc. Price and Consensus
Forty Seven, Inc. Price and Consensus

Forty Seven, Inc. price-consensus-chart | Forty Seven, Inc. Quote

Forty Seven’s shares gained 10.8% over the last one month against the S&P 500’s rise of 4.6%. The company possesses a Momentum Score of B.

Forty Seven, Inc. Price

Forty Seven, Inc. Price
Forty Seven, Inc. Price

Forty Seven, Inc. price | Forty Seven, Inc. Quote

ADVERTISEMENT

Genfit SA (GNFT): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.9% over the last 60 days.

Genfit SA Price and Consensus

Genfit SA Price and Consensus
Genfit SA Price and Consensus

Genfit SA price-consensus-chart | Genfit SA Quote

Genfit’s shares gained 15.8% over the last one month. The company possesses a Momentum Score of A.

Genfit SA Price

Genfit SA Price
Genfit SA Price

Genfit SA price | Genfit SA Quote

U.S. Physical Therapy, Inc. (USPH): This outpatient physical therapy clinics operator has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

U.S. Physical Therapy, Inc. Price and Consensus

U.S. Physical Therapy, Inc. Price and Consensus
U.S. Physical Therapy, Inc. Price and Consensus

U.S. Physical Therapy, Inc. price-consensus-chart | U.S. Physical Therapy, Inc. Quote

U.S. Physical Therapy’s shares gained 7.3% over the last one month. The company possesses a Momentum Score of A.

U.S. Physical Therapy, Inc. Price

U.S. Physical Therapy, Inc. Price
U.S. Physical Therapy, Inc. Price

U.S. Physical Therapy, Inc. price | U.S. Physical Therapy, Inc. Quote

SPX Corporation (SPXC): This infrastructure equipment supplier has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

SPX Corporation Price and Consensus

SPX Corporation Price and Consensus
SPX Corporation Price and Consensus

SPX Corporation price-consensus-chart | SPX Corporation Quote

SPX's shares gained 8.7% over the last one month. The company possesses a Momentum Score of B.

SPX Corporation Price

SPX Corporation Price
SPX Corporation Price

SPX Corporation price | SPX Corporation Quote

See the full list of top ranked stocks here.

Learn more about the Momentum score and how it is calculated here.

Radical New Technology Creates $12.3 Trillion Opportunity

Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.

Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.

See the 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
U.S. Physical Therapy, Inc. (USPH) : Free Stock Analysis Report
 
SPX Corporation (SPXC) : Free Stock Analysis Report
 
Forty Seven, Inc. (FTSV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.